Search
Search Results
##search.searchResults.foundPlural##
-
SUSTAINED REMISSION IN AN ELDERLY PATIENT WITH ACUTE MYELOID LEUKEMIA FOLLOWING GILTERITINIB TREATMENT AS THIRD-LINE SALVAGE THERAPY Long-lasting disease remission with third line therapy with gilteritinib
911PDF: 494HTML: 174 -
THE ROLE OF WHITE BLOOD CELL COUNT IN PERIANAL PATHOLOGIES: A RETROSPECTIVE ANALYSIS OF HEMATOLOGIC MALIGNANCIES Role of white blood cell count in perianal pathologies
2537PDF: 1779HTML: 223 -
CROCIN PROMOTES APOPTOSIS IN HUMAN EBV-TRANSFORMED B-LYMPHOCYTE VIA INTRINSIC PATHWAY CROCIN PROMOTES APOPTOSIS IN EBV-TRANSFORMED LCL
1194PDF: 453HTML: 129 -
ClinicaI Reversible Myelopathy in T-Cell Lymphoblastic Lymphoma Treated with Nelarabine and Radiotherapy: Report of a Case and Review of Literature of an Increasing Complication
2343PDF: 980HTML: 1633Fig 1: 169Tab I: 195Cover Letter: 187 -
Pseudo-differentiation syndrome
1304PDF: 638HTML: 10832Figure 1: peripheral blood showing myeloblasts with auer rods: 106Figure 2: CXR upon presentation to the hospital- no infiltrates nor consolidation changes: 95Figure 3: CXR showing pulmonary infiltartes with consolidation: 121Figure 4: CXR after starting steroid therapy- where the infiltrates have melted away: 95Figure 5: barograph showing the rising TLC ad ANC values- associated with worsening symptoms and increasing pulmonary infiltrates in CXR: 109 -
NUTRITIONALLY VARIANT STREPTOCOCCI BACTEREMIA IN CANCER PATIENTS: A RETROSPECTIVE STUDY, 1999-2014
2035PDF: 971HTML: 4054Cover Letter: 208Figure 1: 211Figure 2: 217Table 1: 191 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4018PDF: 1544HTML: 858 -
miR-155-5p PROMOTES CD34+ APOPTOSIS AND INHIBITS BONE MARROW HEMATOPOIESIS IN MYELODYSPLASTIC SYNDROMES BY RAC1/CREB/MIR-15B AXIS
688PDF: 798PDF Supp. Files: 70HTML: 172 -
HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
1960PDF: 741HTML: 3103 -
REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy
1506PDF: 569HTML: 171 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4729PDF: 1725HTML: 2690Untitled: 197 -
Brief tale of a bacteraemia by Rhodococcus equi with concomitant lung mass: what came first, the chicken or the egg?
1355PDF: 793HTML: 8638Fig 3 Savini: 158Fig 2 Savini: 162Fig 1 Savini Chest TC: 170Author letter to referees: 171 -
ATRA induced Reactive Hemophagocytosis: A Case Report
1185PDF: 560HTML: 2844ATRA induced Reactive Hemophagocytosis: A Case Report: 181 -
HEPATITIS B AND C IN HEMATOPOIETIC STEM CELL TRANSPLANT
942PDF: 521HTML: 711 -
DIAGNOSTIC UTILITY OF FLOW CYTOMETRY IN MYELODYSPLASTIC SYNDROMES.
4720PDF: 1752HTML: 2103 -
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1189PDF: 942HTML: 192 -
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
3997PDF: 1121HTML: 1921Fig.1: 207Fig. 2: 103Table 1: 190Table2: 204Table 3: 184 -
PERIPHERAL NERVOUS SYSTEM INVOLVEMENT IN LYMPHOPROLIFERATIVE DISORDERS
1704PDF: 855HTML: 362Fig1: 218Fig.2: 237Fig. 3: 166Fig. 5: 179Fig. 4: 203 -
ANTIBACTERIAL RESISTANCE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION
4030PDF: 1209HTML: 1946Table 1: 177 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1448PDF: 902HTML: 210 -
LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT
1253PDF: 985HTML: 110







